Komori
M&A and Subsidiary Changes286AEUCALIA Inc.Information & Communications, Services and Others

Notice Regarding the Acquisition of Shares in Medical Planet Co., Ltd. (Making It a Grandchild Subsidiary)

ユカリア will acquire all shares of メディカル・プラネット from ワタキューホールディングス through its wholly owned subsidiary リメディカ, making メディカル・プラネット a sub-subsidiary. Following the acquisition, it will combine リメディカ's operational transformation and technology capabilities with メディカル・プラネット's human resources and customer bases.

Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
1470
JPY million (approximate amount, including advisory fees and other costs)
Wording
Conditional
How definitive the wording is.

This transaction

Share acquisition under this transaction
Counterpartyワタキューホールディングス株式会社
Disclosing companyEUCALIA Inc.
株式会社メディカル・プラネットVoting rights ownership percentageNumber of shares acquired 1,760 shares (number of voting rights: 1,760)

The voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.

TimelineThe spacing between the points is proportional to the actual number of days.
Target company

Outsourced medical administrative services; recruitment and staffing services specializing in healthcare personnel; and businesses relating to specified skilled foreign nationals

Location Minato-ku, TokyoShare capital ¥88 millionDate of incorporation 18 August 2000
Net Sales¥5,877 million (fiscal year ending June 2026)
Operating profit¥263 million (fiscal year ending June 2026)
Net income for the current fiscal year¥179 million (fiscal year ending June 2026)
Net assets¥724 million (fiscal year ending June 2026)
Consideration and expenses
Acquisition priceCommon shares of 株式会社メディカル・プラネット: ¥1,458 million
Expenses other than the acquisition priceAdvisory fees and other expenses (approximate amount): ¥12 million
Impact on Business Performance

Immaterial (ユカリア's consolidated results for the fiscal year ending December 2026)

Procedures and assumptions
Conditions Precedent to ExecutionPrior notification under the Act on Prohibition of Private Monopolization and Maintenance of Fair Trade, expiration of the waiting period and other requirements
Management structure after acquisitionThe employment of メディカル・プラネット's employees, its trade name and its business operating structure are expected to be maintained. While respecting its relationships with customers, the expertise of its on-site personnel and its corporate culture, the parties will consider step by step how to create value going forward.
This transaction
ItemDetails
Transaction nameShare acquisition under this transaction
Counterparty nameワタキューホールディングス株式会社
Name of the Subject Company株式会社メディカル・プラネット
Business Description of the Subject CompanyOutsourced medical administrative services; recruitment and staffing services specializing in healthcare personnel; and businesses relating to specified skilled foreign nationals
Location of the Subject CompanyMinato-ku, Tokyo
Capital Stock of the Subject Company¥88 million
Date of Establishment of the Subject Company18 August 2000
Net Sales of the Subject Company¥5,877 million (fiscal year ending June 2026)
Operating Profit of the Subject Company¥263 million (fiscal year ending June 2026)
Net Income of the Subject Company¥179 million (fiscal year ending June 2026)
Net Assets of the Subject Company¥724 million (fiscal year ending June 2026)
Acquisition priceCommon shares of 株式会社メディカル・プラネット: ¥1,458 million
Expenses other than the acquisition priceAdvisory fees and other expenses (approximate amount): ¥12 million
Number of shares acquired1,760 shares (number of voting rights: 1,760)
Voting rights ownership percentageBefore 0% → after 100%
Impact on Business PerformanceImmaterial (ユカリア's consolidated results for the fiscal year ending December 2026)
Date of board resolution19 November 2026
Contract Date19 November 2026
Execution Date / Effective Date21 December 2026 (scheduled)
Conditions Precedent to ExecutionPrior notification under the Act on Prohibition of Private Monopolization and Maintenance of Fair Trade, expiration of the waiting period and other requirements
Management structure after acquisitionThe employment of メディカル・プラネット's employees, its trade name and its business operating structure are expected to be maintained. While respecting its relationships with customers, the expertise of its on-site personnel and its corporate culture, the parties will consider step by step how to create value going forward.
Items this document does not state (11)
Type of ConsiderationMerger ratio/share exchange ratioTender offer priceMinimum number of shares to be purchasedTender offer periodFunding arrangementsGoodwill amountAmount of extraordinary income (loss)Valuation methodologyIndependent valuation institutionSpecial Committee

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To support both the management and operations of healthcare institutions by combining メディカル・プラネット's expertise in on-site operations, human resources base and nationwide customer base with リメディカ's operational transformation methods and ユカリア's healthcare management support network.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Acquisition of Shares in Medical Planet Co., Ltd. (Making It a Grandchild Subsidiary) | EUCALIA Inc. (286A) timely disclosure | Komori